Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06064604 · ClinicalTrials.gov registry record · NA
Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke
A NA study, sponsored by Georgia Institute of Technology.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06064604 is a NA study that has not yet begun recruiting, run by Georgia Institute of Technology. The registered enrollment target is 20 participants.
The verdict
NCT06064604, a NA study, has not yet begun recruiting, sponsored by Georgia Institute of Technology.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
An exoskeleton device is a robotic system designed to improve an individual's ability to move and perform tasks encountered in everyday situations. These devices consist of external rigid limb segments that assists humans through different body movements with the use of actuators. These devices are controlled by an onboard computer that determines the timing and magnitude of assistance deployed to the user. Exoskeleton controller performance is key to providing beneficial assistance that does not inhibit the user's movement. Preceding work will compare the benefit of personalized hip versus ankle joint exoskeleton assistance for improvement of post-stroke gait. It will combine exoskeleton technology with the user's movement feedback to improve wearable robotic assistance to an individual stroke survivor's gait pattern. For the clinical trial research covered under this protocol, the investigator will test various exoskeleton technologies with stroke survivors in real-world contexts, indoors and outdoors, and measure clinically meaningful outcomes and user perceptions regarding technology usability and adoption. The long-term goal is to deploy self-adaptive, adoptable exoskeletons for personalized assistance during community ambulation.
Interventions
- OTHER Control
- DEVICE Hip Exoskeleton
- DEVICE Ankle Exoskeleton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2027-01-01 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06064604
The ClinicalTrials.gov registry entry for NCT06064604 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgia Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT06064604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06064604 about?
NCT06064604 is a clinical study titled "Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke". An exoskeleton device is a robotic system designed to improve an individual's ability to move and perform tasks encountered in everyday situations. These devices consist of external rigid limb segments that assists humans through different body movements with the use of actuators. These devices are ...
What is the current status of trial NCT06064604?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2027-01-01. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT06064604?
The interventions under investigation include: Control (OTHER), Hip Exoskeleton (DEVICE), Ankle Exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT06064604?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.